Skip to main content
Premium Trial:

Request an Annual Quote

Your Money or Your Meds


Cancer research is moving on stronger than ever, and pharmaceutical companies and biotechs are finding new treatments, says Katherine Hobson at the Wall Street Journal's Health Blog. But those innovations come with a price — cancer drugs are expensive, and the cost keeps going up. Assuming there will be no changes in pricing trends, NCI estimates medical costs due to cancer will hit $158 billion in 2020, and could even go as high as $207 billion, Hobson says. A recent study published jointly by the Journal of Oncology Practice and the American Journal of Managed Care found that 10 percent of patients failed to fill new prescriptions for oral cancer drugs, and experts say it's partly because of the cost to patients, she adds. The study's authors say policymakers need to find ways to lower the cost of cancer prescriptions for patients so that there's no barrier to their receiving the best care possible.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.